MOOD & IA
When your arthritis score won't budge, look at your mood too
Depression and anxiety are not a side story in inflammatory arthritis. They shape your disease activity, your treatment response, and the number on your chart.
Week of July 24, 2026 — Angelo Papachristos PT, ACPAC
Sandra came to clinic with a folder. Three visits' worth of DAS28 scores, all stuck in the same unhappy range, and a question she had rehearsed in the parking lot: was it time to switch biologics again? Her hands ached, she was wrung out by mid-morning, and the number on the page said her rheumatoid arthritis was still active. What the folder did not show was that she had stopped sleeping, had quietly dropped out of her book club, and had cried in the car before coming in.
What you've probably been told about mood and arthritis
The usual message is that feeling low or anxious is a fair reaction to a painful, unpredictable disease. Treat the arthritis, the thinking goes, and the mood will follow. Mood gets filed as something downstream, a problem to deal with once the real work of controlling inflammation is done.
That framing is too tidy, and it does patients like Sandra a disservice. Depression and anxiety are not just reactions sitting on top of the disease. They interact with it, they change how it behaves, and they change how we read your test results. If you treat mood as an afterthought, you can end up escalating powerful drugs to chase a problem the drugs were never going to fix.
The link runs both directions
Depression is common in inflammatory arthritis. Anxiety runs alongside it. These are not rare edge cases, they are part of the disease population. A systematic review of 72 studies in rheumatoid arthritis (Matcham and colleagues, 2013) found 16.8% met formal diagnostic criteria for major depression, close to one in six. On the PHQ-9 questionnaire, which picks up symptoms short of a formal diagnosis, the figure was 38.8%.
Some of this is biology rather than circumstance. The same immune signalling proteins that inflame your joints, cytokines like IL-6 and TNF, also act on the brain. They can produce the low mood, fatigue, poor sleep, and loss of interest that look exactly like depression. This is the biology behind what researchers call sickness behaviour.
The most striking evidence comes from the drugs themselves. A meta-analysis of anti-cytokine treatments across chronic inflammatory diseases (Kappelmann and colleagues, 2018) pooled seven randomised trials and 2,370 patients. Depressive symptoms improved against placebo, and the size of that improvement did not track with how much the physical illness improved. Dampen the inflammation and, for some people, the mood lifts through a route that has nothing to do with joint counts. The relationship runs both ways: inflammation feeds low mood, and low mood tracks with worse disease.
Why this shows up in your disease activity number
Here is the part that matters most for Sandra's folder. Many rheumatology clinics measure rheumatoid arthritis activity with a composite score called the DAS28. It is built from four things. The number of swollen joints, the number of tender joints, a blood marker of inflammation (usually CRP or ESR), and your own overall rating of how you are doing. Two of those, the tender joint count and your global rating, are strongly coloured by mood, sleep, and how your nervous system is processing pain. The other two track the inflammation more directly.
When someone is depressed or anxious, the tender joint count and the global score can climb while the swollen joints stay quiet and the CRP stays normal. The composite score looks like active arthritis. The joints, examined carefully or scanned with ultrasound, tell a calmer story. That was Sandra. Low swollen joint count, normal CRP, but a high tender count and a bleak global rating dragging the whole number up. The question was never really which biologic. It was why the two halves of her score disagreed.
This is not academic. One study followed patients through two years of treatment (Matcham and colleagues, 2016). Those who started with depression or anxiety went on to have higher disease activity scores and higher tender joint counts. Symptoms that persisted did more damage, with worse physical function and lower odds of reaching remission. Untreated mood is one reason a good drug can look like it is failing. The same patients got about half the benefit from prednisolone that everyone else did.
What actually helps, and how much
Psychological therapy earns its place here. A meta-analysis of 25 trials of psychological interventions in rheumatoid arthritis (Astin and colleagues, 2002) found small but real gains from approaches like cognitive behavioural therapy. Small is the honest word. These work best as part of your care rather than instead of it, and a gain in a symptom your biologic was never going to touch is still worth having. The pooled effects were 0.22 for pain, 0.27 for physical disability, and 0.15 for psychological wellbeing.
Not all of them work equally well. A newer analysis ranked 16 psychological therapies across 23 trials and 1,885 patients with rheumatoid arthritis (Zhang and colleagues, 2025). Most made no clear difference to depression. Mindfulness-based cognitive therapy ranked best, and programs that combined more than one approach came second.
Exercise belongs in the same conversation, and its effects reach past your joints. A meta-analysis of 12 randomised trials in systemic lupus erythematosus (He and colleagues, 2026) found improvements in fatigue, pain, physical function, and depression. Movement is one of the few things that shifts mood, fatigue, and function at once. Disease activity itself did not change.
Fear of movement is its own barrier. Naming it and working through it graded and slow is part of the job. In a survey of 180 adults with axial spondyloarthritis (Thompson and colleagues, 2026), higher kinesiophobia, the fear of movement, came with lower odds of meeting physical activity guidelines. Every one-point rise on the fear scale cut the odds of meeting strengthening targets by 11%.
The most promising direction is building this into rheumatology care rather than referring it away. One clinic ran a pilot along those lines (Teaw and colleagues, 2026). Patients picked a goal, either mood, pain, or activity, and got up to eight phone sessions with a behavioural health specialist. Most of their symptom scores improved. It was 28 people with no comparison group, so read it as a signal rather than proof.
Access is the harder problem. Online programs are one answer being tested. A German trial gave 102 adults with rheumatoid arthritis, psoriatic arthritis, or lupus either a self-guided online program or usual care (Knitza and colleagues, 2025). Distress fell further in the online group. Quality of life rose. Meaningful improvement in distress reached 59% there, against 34% on usual care.
The evidence for integrated models is still young. What is not uncertain is the direction: mood screened and treated inside the clinic beats mood ignored until it derails everything else.
What to do, and the conversation to have
If your disease activity score is stuck but your swollen joint count and inflammation blood tests look quiet, ask your team to walk you through which parts of your score are driving the number. If the answer is your tender joints and your own global rating, that is a signal to look at pain processing, sleep, and mood, not only the drug. Be honest about how you are actually doing. A rheumatology team cannot factor in a low mood or a sleep problem you have not told them about, and that missing information can send treatment in the wrong direction.
Ask directly about depression and anxiety screening and about what support exists, whether that is a psychologist, a mindfulness-based cognitive therapy program, a supervised exercise program that targets fatigue and mood as well as joints, or a guided online program if in-person access is limited. Frame it as part of getting your arthritis under control, because it is.
Questions for your care team
- Which parts of my disease activity score are highest right now, my swollen joints and inflammation markers, or my tender joints and global rating?
- Could low mood, anxiety, or poor sleep be part of why my score isn't improving, and can we treat that alongside my medication?
- Can you refer me to psychological support or a program that combines exercise with mood and fatigue management?
- Between visits I'll track my mood, sleep, and energy next to my joint symptoms in a simple weekly note. Which of these matters most for you to see?
What this does not mean
None of this means your pain is imaginary or that it is all in your head. Tender joints hurt whether the cause is inflammation, central pain, or both. And it is not a reason to stop or skip your prescribed medication on your own. The point is to treat mood as part of your arthritis care, so the right problem gets the right treatment.
References
Matcham 2013 - prevalence of depression in RA (systematic review). Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52(12):2136-2148.
https://pubmed.ncbi.nlm.nih.gov/24003249/
Kappelmann 2018 - anti-cytokine treatment and depressive symptoms. Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Molecular Psychiatry. 2018;23(2):335-343.
https://pubmed.ncbi.nlm.nih.gov/27752078/
Matcham 2016 - depression/anxiety predict RA treatment response. Matcham F, Norton S, Scott DL, Steer S, Hotopf M. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial. Rheumatology (Oxford). 2016;55(2):268-278.
https://pubmed.ncbi.nlm.nih.gov/26350486/
Astin 2002 - psychological interventions for RA (meta-analysis). Astin JA, Beckner W, Soeken K, Hochberg MC, Berman B. Psychological interventions for rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis & Rheumatism. 2002;47(3):291-302.
https://pubmed.ncbi.nlm.nih.gov/12115160/
Zhang 2025 - psychological interventions for depressive symptoms in RA (network meta-analysis). Zhang L, Zhu W, Liu S. Psychological interventions for reducing depressive symptoms in rheumatoid arthritis patients: a systematic review and network meta-analysis. Psychology, Health & Medicine. 2025;30(9):1867-1885.
https://pubmed.ncbi.nlm.nih.gov/40153848/
He 2026 - exercise in SLE, effects on fatigue, function, depression (meta-analysis). He Z, Jia S, Chen M, Shi X, Hu L, Li F, Shi H, Nieman DC, Shi Y. Effects of exercise interventions on core health outcomes in patients with SLE: systematic review and meta-analysis. Lupus Science & Medicine. 2026;13(1):e002027.
https://pubmed.ncbi.nlm.nih.gov/42373138/
Thompson 2026 - kinesiophobia and physical activity in axSpA. Thompson JR, Goodwin JFS, Vallabhajosula S, Baez S, Thoma L. Kinesiophobia and physical activity participation in axial spondyloarthritis: a cross-sectional study during the COVID-19 pandemic. Clinical Rheumatology. 2026.
https://pubmed.ncbi.nlm.nih.gov/42329348/
Teaw 2026 - integrating behavioral health into rheumatology care (pilot). Teaw S, Link-Malcolm J, Ghebranious M, Patterson DJ, Foster J, Bereket S, Wahid U, Bajaj P, Solow EB, Hynan LS, Barton JL, Makris UE. Integrating behavioral health services for individuals with rheumatic diseases: a quantitative analysis of a pilot study. ACR Open Rheumatology. 2026;8(7):e90095.
https://pubmed.ncbi.nlm.nih.gov/42487220/
Knitza 2025 - digital psychological intervention in inflammatory rheumatic disease (randomised trial). Knitza J, Kraus J, Krusche M, Haase I, Klemm P, Hueber AJ, Pfeil A, Drott U, Kuhn S, Klein JP. Digital psychological intervention for inflammatory rheumatic diseases: a pilot randomized clinical trial. JAMA Network Open. 2025;8(9):e2529892.
https://pubmed.ncbi.nlm.nih.gov/40924426/
This article is for education and is not medical advice. It cannot replace an individual assessment by your own rheumatology or mental health team, who know your history and your medications. Do not change or stop any prescribed treatment based on what you read here. If you are experiencing thoughts of harming yourself, contact your local emergency services or a crisis line right away.
_Angelo Papachristos PT, ACPAC — Advanced Practice Physiotherapist